This review aims to summarize the current knowledge on the potential associations of leptin genetics with the main pathogenic pathways of obesity and CRC, in an attempt to understand the molecular mechanisms of these associations, in the context of inconsistent and contradictory data. The gene discussed is LEP; the disease is colorectal carcinoma.